Clinical Pharmacology Study of CS-3150 Drug-drug interaction Study between CS-3150 and digoxin or rifampicin in healthy Japanese subjects.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Esaxerenone (Primary) ; Digoxin; Rifampicin
- Indications Diabetic nephropathies; Essential hypertension; Hyperaldosteronism; Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 24 Apr 2017 Status changed from active, no longer recruiting to completed.
- 09 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 28 Nov 2016 New trial record